Industry Profile

Neurodegenerative Disease Research

Target researchers — Neuroscientists, neuropathologists, and translational researchers specializing in protein aggregation, neuroinflammation, tau biology, alpha-synuclein, TDP-43, lysosomal pathways, and CNS drug delivery across Alzheimer's, Parkinson's, and ALS models

Neurodegenerative disease companies develop treatments for Alzheimer's, Parkinson's, ALS, and frontotemporal dementia, where academic research provides the majority of validated targets, biomarkers, and disease models. The field recruits neuroscientists from top medical schools and licenses iPSC neuron platforms, CRISPR screening results, and biomarker assays from university partners.

Key Companies